16+
Major trials tracked
GLP-1 & incretin therapies · Live ClinicalTrials.gov data
Cagrilintide clinical trial pipeline
The timeline below tracks the 16 largest phase 2–4 cagrilintide trials on ClinicalTrials.gov by enrolment, 2 of them actively recruiting. The next phase 3 primary completion among them is expected Mar 2027. Refreshed daily — add up to four competitors to compare pipelines side by side.
14
Phase 3 trials
2
Actively recruiting
Mar 2027
Next phase 3 primary completion
23,553
Participants across trials
Novo Nordisk A/S
Lead sponsor by trial count
cagrilintide (16)8 active2019–2031
cagrilintide
'19
'20
'21
'22
'23
'24
'25
'26
'27
'28
'29
'30
'31
cagrilintide
Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.P2
REDEFINE 1P3
REDEFINE 2P3
REDEFINE 3P3
A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose WeightP3
REIMAGINE 2P3
A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose WeightP3
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorP3
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and PlaceboP2
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose WeightP3
REIMAGINE 5P3
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With ObesityP3
A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-termP3
RENEW 2P3
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body WeightP3
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightP3
Upcoming readouts
6 ahead · cagrilintide
Select a trial to load its full ClinicalTrials.gov record.
Key cagrilintide trials
Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Each links to its full ClinicalTrials.gov record.
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT07564414 | A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Livin… | Phase 3 | Recruiting | Feb 2028 |
| NCT07253285 | A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weig… | Phase 3 | Recruiting | Mar 2030 |
| NCT05567796 | REDEFINE 1 — A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight | Phase 3 | Active, not recruiting | Oct 2024 |
| NCT06534411 | REIMAGINE 5 — A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in Peopl… | Phase 3 | Active, not recruiting | Jun 2026 |
| NCT07011667 | A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weigh… | Phase 3 | Active, not recruiting | Mar 2027 |
| NCT07220759 | RENEW 2 — Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilint… | Phase 3 | Active, not recruiting | May 2027 |
| NCT05669755 | REDEFINE 3 — REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and B… | Phase 3 | Active, not recruiting | Sept 2027 |
| NCT06780449 | A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity | Phase 3 | Active, not recruiting | Aug 2028 |
| NCT05813925 | A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight | Phase 3 | Completed | Jan 2025 |
| NCT05394519 | REDEFINE 2 — A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weigh… | Phase 3 | Completed | Jan 2025 |
| NCT06065540 | REIMAGINE 2 — A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Suga… | Phase 3 | Completed | Nov 2025 |
| NCT06131437 | A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight | Phase 3 | Completed | Dec 2025 |
Related drug pipelines
FAQ
- How many clinical trials are running for cagrilintide?
- ClinicalTrials.gov lists more than 16 phase 2–4 cagrilintide trials. This page tracks the 16 largest by enrolment: 2 phase 2, 14 phase 3, and 0 phase 4 among them, with 2 actively recruiting. Updated daily.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare cagrilintide against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist
Be the first to access ComplyRx
We'll let you know as soon as your spot opens to use ComplyRx.
By joining, you agree to our Privacy Policy.